Novartis Restructuring Continues as Pharmaceuticals Division Splits, Along With Pharma CEO, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 05/27/16 -- Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas) -- One of the ''s top three drug makers, Swiss-based Novartis International AG (NYSE:NVS) (Basel, has restructured its pharmaceuticals division by creating two business units -- Novartis Pharmaceuticals and Novartis Oncology. Coinciding with the organizational split, the division head and chief executive officer of the company''s Pharmaceuticals division, David Epstein, called it quits.
For details, , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info''s quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what''s happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Brian Ford
(713) 980-9393
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.05.2016 - 05:30 Uhr
Sprache: Deutsch
News-ID 1437912
Anzahl Zeichen: 2564
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Machinery & Tools
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 516 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novartis Restructuring Continues as Pharmaceuticals Division Splits, Along With Pharma CEO, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
